Terms: = Germ cell tumor AND TRIM24, O15164, 8805, ENSG00000122779, TIF1ALPHA, TF1A, TIF1A, hTIF1, Tif1a, TIF1, RNF82, PTC6
18 results:
1. Targeting trim24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex.
Shi Q; Yu B; Zhang Y; Yang Y; Xu C; Zhang M; Chen G; Luo F; Sun B; Yang R; Li Y; Feng H
Cell Oncol (Dordr); 2023 Dec; 46(6):1763-1775. PubMed ID: 37466744
[TBL] [Abstract] [Full Text] [Related]
2. Valproic Acid Inhibits Glioma and Its Mechanisms.
Yang ZY; Wang XH
J Healthc Eng; 2022; 2022():4985781. PubMed ID: 35251569
[TBL] [Abstract] [Full Text] [Related]
3. Pharmacological targeting of Tripartite Motif Containing 24 for the treatment of glioblastoma.
Han M; Sun Y
J Transl Med; 2021 Dec; 19(1):505. PubMed ID: 34886858
[TBL] [Abstract] [Full Text] [Related]
4. TERT gene rearrangement in chordomas and comparison to other TERT-rearranged solid tumors.
Yoon JY; Jiang W; Orr CR; Rushton C; Gargano S; Song SJ; Modi M; Hozack B; Abraham J; Mallick AB; Brooks JSJ; Rosenbaum JN; Zhang PJ
Cancer Genet; 2021 Nov; 258-259():74-79. PubMed ID: 34583232
[TBL] [Abstract] [Full Text] [Related]
5. Severe onset of inflammatory myositis in a child: think to paraneoplastic myositis.
Benvenuto S; Gortani G; Bussani R; Poropat F; Murru FM; Carrozzi M; Tommasini A; Taddio A
Ital J Pediatr; 2021 Jul; 47(1):146. PubMed ID: 34210321
[TBL] [Abstract] [Full Text] [Related]
6. trim24 promotes stemness and invasiveness of glioblastoma cells via activating Sox2 expression.
Zhang LH; Yin YH; Chen HZ; Feng SY; Liu JL; Chen L; Fu WL; Sun GC; Yu XG; Xu DG
Neuro Oncol; 2020 Dec; 22(12):1797-1808. PubMed ID: 32492707
[TBL] [Abstract] [Full Text] [Related]
7. Long non-coding RNA NCK1-AS1 promotes the tumorigenesis of glioma through sponging microRNA-138-2-3p and activating the trim24/Wnt/β-catenin axis.
Huang L; Li X; Ye H; Liu Y; Liang X; Yang C; Hua L; Yan Z; Zhang X
J Exp Clin Cancer Res; 2020 Apr; 39(1):63. PubMed ID: 32293515
[TBL] [Abstract] [Full Text] [Related]
8. NCK1-AS1 Increases Drug Resistance of Glioma cells to Temozolomide by Modulating miR-137/
Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H
Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728
[No Abstract] [Full Text] [Related]
9. A novel case of tif1 gamma autoantibody positive dermatomyositis associated with a non-functional pancreatic neuroendocrine tumor.
Varedi D; Frigerio A; Scaife C; Hull C
Dermatol Online J; 2019 Mar; 25(3):. PubMed ID: 30982303
[TBL] [Abstract] [Full Text] [Related]
10. trim24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma.
Lv D; Li Y; Zhang W; Alvarez AA; Song L; Tang J; Gao WQ; Hu B; Cheng SY; Feng H
Nat Commun; 2017 Nov; 8(1):1454. PubMed ID: 29129908
[TBL] [Abstract] [Full Text] [Related]
11. Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through trim24 Binding.
Lv D; Jia F; Hou Y; Sang Y; Alvarez AA; Zhang W; Gao WQ; Hu B; Cheng SY; Ge J; Li Y; Feng H
Cancer Res; 2017 Nov; 77(22):6190-6201. PubMed ID: 29021135
[TBL] [Abstract] [Full Text] [Related]
12. Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles.
Bertrand D; Chng KR; Sherbaf FG; Kiesel A; Chia BK; Sia YY; Huang SK; Hoon DS; Liu ET; Hillmer A; Nagarajan N
Nucleic Acids Res; 2015 Apr; 43(7):e44. PubMed ID: 25572314
[TBL] [Abstract] [Full Text] [Related]
13. Melanoma and IFN alpha: potential adjuvant therapy.
Bottoni U; Clerico R; Paolino G; Corsetti P; Ambrifi M; Brachini A; Richetta A; Nisticò S; Pranteda G; Calvieri S
J Biol Regul Homeost Agents; 2014; 28(2):271-9. PubMed ID: 25001659
[TBL] [Abstract] [Full Text] [Related]
14. trim24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway.
Zhang LH; Yin AA; Cheng JX; Huang HY; Li XM; Zhang YQ; Han N; Zhang X
Oncogene; 2015 Jan; 34(5):600-10. PubMed ID: 24469053
[TBL] [Abstract] [Full Text] [Related]
15. BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition.
Hutchinson KE; Lipson D; Stephens PJ; Otto G; Lehmann BD; Lyle PL; Vnencak-Jones CL; Ross JS; Pietenpol JA; Sosman JA; Puzanov I; Miller VA; Pao W
Clin Cancer Res; 2013 Dec; 19(24):6696-702. PubMed ID: 24345920
[TBL] [Abstract] [Full Text] [Related]
16. Anti-MDA5 and anti-tif1-gamma antibodies have clinical significance for patients with dermatomyositis.
Hoshino K; Muro Y; Sugiura K; Tomita Y; Nakashima R; Mimori T
Rheumatology (Oxford); 2010 Sep; 49(9):1726-33. PubMed ID: 20501546
[TBL] [Abstract] [Full Text] [Related]
17. Synergistic action of genistein and cisplatin on growth inhibition and cytotoxicity of human medulloblastoma cells.
Khoshyomn S; Manske GC; Lew SM; Wald SL; Penar PL
Pediatr Neurosurg; 2000 Sep; 33(3):123-31. PubMed ID: 11096359
[TBL] [Abstract] [Full Text] [Related]
18. Differential effects of retinoic acid isomers on the expression of nuclear receptor co-regulators in neuroblastoma.
Lovat PE; Annicchiarico-Petruzzelli M; Corazzari M; Dobson MG; Malcolm AJ; Pearson AD; Melino G; Redfern CP
FEBS Lett; 1999 Feb; 445(2-3):415-9. PubMed ID: 10094499
[TBL] [Abstract] [Full Text] [Related]
